Paragon 28
-
Extremities
Paragon 28 Launches Monkey Rings™ Circular External Fixation System
June 9, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot…
Read More » -
Extremities
Paragon 28 Launches TenoTac™ 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair
May 19, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot…
Read More » -
Extremities
Paragon 28 Expands Soft Tissue Portfolio with Grappler™ Suture Anchor System Launch
May 17, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot…
Read More » -
Financial
Paragon 28 Reports First Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
May 9, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the…
Read More » -
Extremities
Paragon 28 Launches Paratrooper™ Plantar Plate System for Hammertoe and Soft Tissue Repair
April 27, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot…
Read More » -
Extremities
Paragon 28 Launches R3ACT™ Stabilization System for Ankle Injuries
April 19, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot…
Read More » -
Extremities
Paragon 28 Announces Appointment of Meghan Scanlon to Board of Directors
March 28, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot…
Read More » -
Financial
Paragon 28 Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Net Revenue Guidance
March 8, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively…
Read More » -
Extremities
Paragon 28 Announces Acquisition of Disior
Disior advances Paragon 28’s SMART 28™ strategy, providing a comprehensive 3D analytics and pre-operative planning platform, and will immediately accelerate…
Read More » -
Financial
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2021
January 10, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively…
Read More » -
Regulatory
Paragon 28, Inc. R3ACT™ Stabilization System Cleared by FDA
December 29, 2021 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the…
Read More » -
Extremities
Paragon 28’s Patient Specific Titanium Talus Spacer Has Been Approved by the U.S. Food and Drug Administration
December 13, 2021 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) announced today that it has received a supplemental approval order from…
Read More » -
Extremities
Paragon 28 Announces Addition of B. Kristine Johnson and Kristina Wright to its Board of Directors
December 1, 2021 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the…
Read More » -
Financial
Paragon 28 Reports Third Quarter 2021 Financial Results and Provides 2021 Fourth Quarter Net Revenue Guidance
November 22, 2021 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the…
Read More » -
Extremities
Paragon 28, Inc. Circular External Fixation System Cleared by FDA
November 15, 2021 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the…
Read More »